Company Filing History:
Years Active: 2023
Title: Keqinq Wang: Innovator in Angiogenesis Modulation
Introduction
Keqinq Wang is a notable inventor based in Birmingham, GB. He has made significant contributions to the field of medical science, particularly in the treatment of various disorders related to angiogenesis. His innovative approach focuses on utilizing micro RNA (miRNA) to address critical health issues.
Latest Patents
Keqinq Wang holds a patent for a method of treating preeclampsia, fetal growth restriction, obesity in pregnancy, post-partum cardiomyopathy, cancer, and diabetic retinopathy. The invention provides a comprehensive method that modulates the activity of micro RNA to treat these conditions. The patent outlines the use of miRNA modulators or their functional fragments for therapeutic purposes. Additionally, it includes methods of modulating angiogenesis and pharmaceutical compositions using specific miRNAs, along with diagnostic methods utilizing these miRNAs.
Career Highlights
Throughout his career, Keqinq Wang has worked with reputable organizations such as Mirzyme Therapeutics Limited and Aston University. His work has been instrumental in advancing the understanding and treatment of disorders where angiogenesis is either diminished or exacerbated.
Collaborations
Keqinq Wang has collaborated with notable colleagues, including Meng Cai and Asif Ahmed. Their combined expertise has contributed to the development of innovative solutions in the medical field.
Conclusion
Keqinq Wang's contributions to the field of angiogenesis modulation highlight his role as a pioneering inventor. His work continues to impact the treatment of various medical conditions, showcasing the importance of innovation in healthcare.